Bowhead Specialty Holdings, Inc. (BOW)
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
$33.65+0.03%
Close 2026-09-04 · 1-day change
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-04
Intact: The reason to own it still holds.
Bowhead Specialty Holdings aims for 20% growth in gross written premiums in 2026. The company maintains EPS guidance at $0.48 for 2026, supported by strong Q1 net income. It has a robust capital base and positive M&A activity. The stock trades at a justified premium with solid analyst revenue growth expectations.
EPS guidance at $0.48 may be optimistic given mixed management status. Debt issuance and capital obligations could pressure financial flexibility. Elevated risk and expensive valuation may limit upside if growth slows.
The market prices in about 24% revenue growth and a 23% premium over our fair value near $26. Our fair value is below the Street median, reflecting cautious optimism. We see value in the growth but note valuation is rich.
Breaks if: EPS falls below $0.45 in FY26
Breaks if: GWP growth falls below 15% YoY in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a durable compounder with a focus on growth in gross written premiums. The current thesis state is intact, supported by strong recent financial results, though risks remain elevated.
The market appears to have priced in a justified valuation, reflecting a durable premium compared to peers. There is an expectations gap indicating that the market may not fully anticipate future performance.
Management is on track to achieve 20% growth in gross written premiums for 2026, with recent results showing strong year-over-year increases. However, maintaining earnings per share guidance could be mixed, and near-term risks are present due to the company's smaller size.
The long-term thesis hinges on the performance of sector bellwethers like CB, PGR, and TRV. Positive earnings and guidance from these companies could support BOW, while any misses could negatively impact sentiment.
The most important moves since the prior daily snapshot.
risk label changed from 'moderate' to 'elevated'.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Continue growing gross written premiums by around 20% in 2026, driven by the Casualty division and digital underwriting platforms.
Stated as a priority in 3 of last 3 quarters. Gross written premiums grew from $174.8 million in 2025-Q1 to $297.9 million in 2026-Q2, a 28.2% increase year-over-year in Q2. Management has consistently emphasized 20% GWP growth in 2026, and the trajectory is delivering above that target.
“Gross written premiums increased 28.2% to $297.9 million in Q2 2026.”
“Gross written premiums increased 24.0% to $216.7 million in Q1 2026.”
“We continue to expect a GWP growth of around 20% in 2026 driven by our Casualty division.”
Breaks if: Material weakening or termination of key reinsurance agreements
Continue to improve and amend reinsurance agreements to support underwriting discipline and risk management.
Stated as a priority in 2 of last 3 quarters. Management amended the quota share reinsurance agreement in 2026-Q2 and discussed reinsurance impacts on expense ratios in 2026-Q1. This shows ongoing focus on reinsurance agreements with moderate progress.
“Entered into Amendment No. 1 to the Amended and Restated Quota Share Reinsurance Agreement.”
“Management discussed reinsurance treaties and ceding commissions impacting expense ratios.”
Over the next one to three years, BOW's performance will depend on its ability to navigate sector dynamics and maintain growth targets. Not investment advice.